logo
GLP-1 drugs increase risk of acid reflux, GERD, study finds

GLP-1 drugs increase risk of acid reflux, GERD, study finds

UPI15-07-2025
People with type 2 diabetes were more likely to suffer from gastroesophageal reflux disease if they were prescribed a GLP-1 drug compared to those taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors, researchers reported Tuesday in the Annals of Internal Medicine. Photo by Robystarm/ Pixabay
July 14 (UPI) -- Folks using GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, a new study says.
People with type 2 diabetes were more likely to suffer from gastroesophageal reflux disease (GERD) if they were prescribed a GLP-1 drug compared to those taking sodium-glucose cotransporter-2 (SGLT-2) inhibitors, researchers reported Tuesday in the Annals of Internal Medicine.
"We estimated that most GLP-1 [drugs] increased risk for GERD," concluded the research team led by Laurent Azoulay, an associate professor with the Jewish General Hospital's Center for Clinical Epidemiology in Montreal, Canada.
The risk for serious GERD-related complications was higher among smokers, people with obesity and folks with existing stomach problems, researchers said.
"Although our findings need to be corroborated in other studies, clinicians and patients should be aware of a possible adverse effect of GLP-1 [drugs] on GERD," researchers noted.
For the study, researchers tracked more than 24,700 type 2 diabetics newly prescribed GLP-1 drugs, comparing their health to that of more than 89,000 who were prescribed SGLT-2 inhibitors.
Glucagon-like peptide-1 (GLP-1) drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food.
Because the drugs slow the rate at which food passes through the stomach, researchers thought they might increase the risk of acid reflux.
GERD occurs when acid reflux happens repeatedly over time, the Mayo Clinic says. If it continues, GERD can cause scarring and narrowing of the esophagus and increase a person's risk of esophageal cancer.
Results show that people taking GLP-1 drugs were 27% more likely to develop GERD and 55% more likely to have GERD complications, when compared to people taking SGLT-2 inhibitors.
More than 90% of GERD complications involved Barrett esophagus, in which acid damage changes the tissue lining of the esophagus and increases cancer risk, researchers noted.
"We also found that the risk for GERD was higher with long-acting GLP-1 (drug) use," researchers wrote.
However, they noted that these findings need to be verified by studies involving other groups, including those taking GLP-1 drugs for obesity.
"There is limited evidence on the risk for GERD among patients with obesity who do not have type 2 diabetes," researchers wrote. "Use of GLP-1 [drugs] is rapidly expanding in this population, highlighting an important area for future research."
More information
The Mayo Clinic has more on GERD.
Copyright © 2025 HealthDay. All rights reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Justin Timberlake reveals Lyme disease diagnosis
Justin Timberlake reveals Lyme disease diagnosis

UPI

time6 hours ago

  • UPI

Justin Timberlake reveals Lyme disease diagnosis

Justin Timberlake arrives on the red carpet at the 2019 Songwriters Hall Of Fame at The New York Marriott Marquis in New York City. The pop singer and actor revealed Thursday that he has been diagnosed with Lyme disease. File Photo by John Angelillo/UPI | License Photo July 31 (UPI) -- Pop singer and actor Justin Timberlake has revealed that he is suffering from a "debilitating" case of Lyme disease during his Forget Tomorrow World Tour, he announced on social media. In an Instagram post Thursday, Timberlake said he wanted to "shed some light" on his battle and what he has been going through since his recent diagnosis. "Living with this can be relentlessly debilitating both mentally and physically," he wrote in the social media post. "When I first got the diagnosis I was shocked for sure. But at least I could understand why I would be onstage and in a massive amount of nerve pain or just feeling crazy fatigue and sickness." Timberlake, 44, who is typically reserved about sharing personal details, said he was faced with the difficult decision to stop touring or push through the pain the disease was causing, and ultimately decided to stay on the road because "the joy that performing brings me far outweighs the fleeting stress my body was feeling." "I'm so glad I kept going," he wrote. The Grammy-winning performer also said in his post that he wanted to help others who may be experiencing symptoms of the disease. Lyme disease is typically transmitted through a tick bite and its symptoms can include flu-like conditions, dizziness, chest pain, palpitations, arthritis, facial nerve paralysis, ongoing joint pain, fatigue, depression and other neurological, rheumatological and cardiovascular symptoms. Timberlake began his most recent tour inApril 2024, and performed the final show Wednesday in Istanbul.

New tariffs could raise prices of Ozempic, Wegovy
New tariffs could raise prices of Ozempic, Wegovy

The Hill

time7 hours ago

  • The Hill

New tariffs could raise prices of Ozempic, Wegovy

(NEXSTAR) – A trade deal between the U.S. and the European Union is expected to impose a 15% tax on pretty much all goods imported from Europe, from fancy French wines to sleek German cars and in-demand pharmaceuticals. Some of the most recognizable brand names that could be impacted include Ozempic and Wegovy, two injectable drugs that have grown popular in recent years for their abilities to treat diabetes and promote weight loss. Both are made by Novo Nordisk, a Danish company. But the European drugs are extremely popular here in the U.S. Wegovy – the version of the drug that's FDA-approved to treat obesity – has about 200,000 weekly prescriptions in the U.S., according to Novo Nordisk. Even before the new tariffs, many people have found the medications to be prohibitively expensive. Without insurance, they cost about $500 a month. What is the Presidential Fitness Test? It's usually cheaper for those who can get the drug covered by their health plan. Novo says of its patients who have coverage in the U.S., 85% pay $25 or less per month. After the tariffs take effect, the prices of importing these medications into the U.S. will go up, but who will pay that tax isn't straightforward. Rena Conti, an associate professor at Boston University's Questrom School of Business, told NBC News that drug companies could just raise their price list right away to offset the higher cost. Those without insurance might notice the sticker price change, but those with coverage could end up paying more in higher premiums. 'The big picture is: The cost of imported drugs is about to become more expensive for all Americans,' Joe Brusuelas, principal and chief economist for RSM US, said in an interview with Axios. Other name-brand drugs like Botox, Viagra and Keytruda (a cancer medication) are also manufactured in Europe and impacted by the tariffs. Some drug generics were supposed to be carved out of the deal, but details were still pending as of Thursday. When asked how Ozempic and Wegovy would be impacted by the new 15% tariff, a Novo Nordisk spokesperson told Nexstar the company 'remains focused on improving patient access and affordability, and we will continue to work to find solutions that help people access the medication they need.'

Report: Hulk Hogan died of a heart attack
Report: Hulk Hogan died of a heart attack

UPI

time8 hours ago

  • UPI

Report: Hulk Hogan died of a heart attack

Retired professional wrestler Hulk Hogan reaches out to fans as he arrives at Randall's Wines and Spirits for a signing appearance in St. Louis in 2024. Hogan, whose real name is Terry Gene Bollea, died July 24. His cause of death, a heart attack, was announced Thursday. File Photo by Bill Greenblatt/UPI | License Photo July 31 (UPI) -- Former pro wrestling star turned political activist Hulk Hogan, who died a week ago at the age of 71, was the victim of a heart attack officials announced Thursday. Hogan, whose real name was Terry Bollea, died of a myocardial infarction, commonly known as a heart attack, according to cremation reports obtained by ABC News through the Pinellas County Forensic Science Center. Hogan's cause of death was certified by his primary care physician. The report indicated that the former WWE star also suffered from atrial fibrillation and chronic lymphocytic leukemia, known as CLL, a type of blood cancer of the blood and bone marrow, according to the National Cancer Institute. A heart attack is typically associated with coronary artery disease which causes severe blood vessel blockages that prohibit enough blood from getting to the heart, according to the Centers for Disease Control and Prevention. Hogan's wife, Sky Daily, wrote on social media that the wrestling star also suffered complications leading up to his death, but she did not specify what they were. "He had been dealing with some health issues," but I truly believed we would overcome them," she wrote in the July 25 social media post. "I had so much faith in his strength. I thought we still had some more time. "This loss is sudden and impossible to process. To the world, he was a legend... but to me, he was my Terry. The man I loved. My partner. My heart." Clearwater, Fla. police and medical personnel responded to a "cardiac arrest" medical call at 9:51 a.m. EDT on July 24 at Hogan's home in Clearwater Beach on the Florida Gulf Coast, near Tampa. He was treated on the scene and then transported to a local hospital where he was pronounced dead.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store